Rubedo Life Sciences is discovering and developing medicines that can improve biological health. During aging, cells become less functional due to the accumulation of damage with some becoming pathogenic, known as senescent cells. Rubedo is using their AI-driven drug discovery platform to identify compounds that can selectively target these senescent cells, while preserving healthy cells, to rejuvenate tissues and reverse disease progression. Ultimately, Rubedo aims to create the universal medicine that provides longevity and youth and cures all diseases.

Rubedo Life Sciences

Founded: 2018
Location: Sunnyvale, CA
Employee range: 11 - 50
Clinical stage: RD
Therapy area: IPF, COVID-19, undisclosed
Drug types: LNG, INF, GER, DRM, HEP, MUS
Lead product: RBO-0618
Funding: $12M seed Dec 2020

Drug notes:

About:

Jobs: